Transcribed
S1E52 Antidepressants (SSRI, SNRI, TCA, MAOI, Atypical)
Nov 26, 2023 ·
49m 24s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
S1E52 Antidepressants (SSRI, SNRI, TCA, MAOI, Atypical)
This is an automatically generated transcript. Please note that complete accuracy is not guaranteed.
Description
High Yield Psychiatric Medications Antidepressants Review for your PANCE, PANRE, Eor's and other Physician Assistant exams. Review includes SSRI's, SNRIs, TCAs, MAOIs, Atypical antidepressants, Serotonin modulators. TrueLearn PANCE/PANRE SmartBank: https://truelearn.referralrock.com/l/CRAMTHEPANCE/...
show more
High Yield Psychiatric Medications Antidepressants Review for your PANCE, PANRE, Eor's and other Physician Assistant exams. Review includes SSRI's, SNRIs, TCAs, MAOIs, Atypical antidepressants, Serotonin modulators.
TrueLearn PANCE/PANRE SmartBank:
https://truelearn.referralrock.com/l/CRAMTHEPANCE/
Discount code for 15% off: CRAMTHEPANCE
Included in review: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Desvenlafaxine, Duloxetine, Levomilnacipran , Milnacipran, Venlafaxine, Amitriptyline, Clomipramine, Doxepin, Imipramine, Trimipramine, Desipramine, Nortriptyline, Protriptyline, Tranylcypromine, Isocarboxazid, Phenelzine Selegiline, Bupropion, Mirtazapine, Trazodone
show less
TrueLearn PANCE/PANRE SmartBank:
https://truelearn.referralrock.com/l/CRAMTHEPANCE/
Discount code for 15% off: CRAMTHEPANCE
Included in review: Citalopram, Escitalopram, Fluoxetine, Fluvoxamine, Paroxetine, Sertraline, Desvenlafaxine, Duloxetine, Levomilnacipran , Milnacipran, Venlafaxine, Amitriptyline, Clomipramine, Doxepin, Imipramine, Trimipramine, Desipramine, Nortriptyline, Protriptyline, Tranylcypromine, Isocarboxazid, Phenelzine Selegiline, Bupropion, Mirtazapine, Trazodone
Information
| Author | Cram The PANCE |
| Organization | Cram The PANCE |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
Comments